Connor James B. 4

What Happened Connor James, a director of Prologis, received a grant of 1,695 Deferred Stock Units (DSUs) on April 28, 2026 and on the same date converted previously granted DSUs/Dividend Equivalent Units (DEUs) into common stock. The filing shows (a) an award/acquisition of 1,695 DSUs at $0.00, (b) an acquisition via exercise/conversion of 1,984 shares at $0.00, and (c) a disposition/conversion entry of 1,984.549 shares at $0.00. All transactions show $0 cash price and thus no purchase proceeds or cash sale proceeds were reported.

Key Details

• Transaction date: April 28, 2026 (reported on Form 4 filed Apr 30, 2026).
• Items reported:
  • Grant/Award (A): 1,695 DSUs @ $0.00 (acquired).
  • Exercise/Conversion (M): 1,984 shares @ $0.00 (acquired).
  • Exercise/Conversion (M) / Disposal line: 1,984.549 shares @ $0.00 (disposed).
• Shares owned after transaction: not specified in the excerpt; the Form 4 balance (column 9) includes DSUs and DEUs — see the full filing for the exact balance.
• Filing timeliness: appears timely (transaction date Apr 28; Form 4 filed Apr 30).
• Footnotes: DSUs vest per plan rules (new DSUs vest 100% on earlier of one-year anniversary or next annual meeting and are generally deferred until Apr 28, 2029); DSUs/DEUs convert 1-for-1 into common stock, earn dividend equivalents, and have no exercise price or expiration (see F1–F3).

Context

• DSUs are long‑term, non‑cash awards that convert into shares 1-for-1 when vested/released; they are not market purchases or sales. The $0.00 price reflects conversion/settlement mechanics rather than a market trade.
• The conversion/release showing both acquisition and disposition lines reflects conversion/release activity of deferred units into shares (see footnote F2). These transactions are routine plan-related events and do not necessarily indicate a buy or sell decision in the open market.